Being the first R&D to retail cannabis player in India, the company is pioneering the use of several cutting edge technological innovations to ensure the responsible dispensing of cannabis based medication by doctors.

India’s first fully integrated research to retail venture in the Ayurvedic Cannabis (Bhang) sector, HempStreet, has secured $1 million in Pre-Series A Funding round. This Pre-Series A funding was led by Pharmacon Holdings, a US based Pharma Tech company and Romain Barberis, a long time private investor in the Cannabis space in the US and Canada. The company has plans to utilise the funds for technology development, category disruption and research.